EVP, General Counsel, Corp Sec
Mon, Mar 10, 2025
Mar 10
exercised or converted securities in ANIK
5,465 shares @ $0.00
Decreased holdings by -50.00%
Net across this filing: +11.30% (+3,861 shares)
ANIKAnika Therapeutics, Inc.
HealthcareDrug Manufacturers - Specialty & Generic
1D+0.28%
1W-0.79%
1M+43.14%
3M+44.50%
6M—
1Y—